Patent · US Active

Modulators of eukaryotic initiation factor 2B, compositions and methods

US11236100B2 · kind B2 · utility

1Cited by
8References
30Claims
0Family size

Assignee

Inventors

Key dates

Filing dateAug 8, 2018
Grant dateFeb 1, 2022
Priority date—
Expiry dateAug 8, 2038

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07C2602/38
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present disclosure relates generally to eukaryotic initiation factor 2B modulators, or a pharmaceutically acceptable salt, stereoisomer, mixture of stereoisomers or prodrug thereof, and methods of making and using thereof.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.